A major breakthrough in cancer research is occurring with the use of nanobodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently inactivated in many types of cancer, resulting https://social40.com/story7535673/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-cancer-management